CD4+ T cell epitope discovery and rational vaccine design

Archivum Immunologiae et Therapiae Experimentalis

Volumn 58, Issue 2, 2010, Pages 121-130

  Rosa, Daniela Santoro ^a,b   Ribeiro, Susan Pereira ^a,b   Cunha Neto, Edecio ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Investigation in Immunology iii   (Brazil)

Author keywords

CD4+ T cells; Epitope prediction; Epitope based vaccines; T cell help; Vaccine design

Indexed keywords

EPITOPE; INTERLEUKIN 12; INTERLEUKIN 15; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VACCINE;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; ALGORITHM; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER PREDICTION; COMPUTER PROGRAM; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DESIGN; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFORMATION RETRIEVAL; REVIEW; ANIMAL; BIOLOGY; DATA MINING; EPITOPE MAPPING; IMMUNE EVASION; IMMUNOLOGY; MOLECULAR EVOLUTION;

ALGORITHMS; ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; DATA MINING; DRUG DESIGN; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; HUMANS; IMMUNE EVASION; IMMUNODOMINANT EPITOPES; VACCINES;

EID: 77952762373     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-010-0067-0     Document Type: Review

References (91)

1. J Alexander J Sidney S Southwood, et al. 1994 Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides immunity 1 751 761 1:CAS:528:DyaK2MXislWktL4%3D
2. CJ Barker KW Beagley LM Hafner, et al. 2008 In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB Vaccine 26 1285 1296 10.1016/j.vaccine.2007.12.048 1:CAS:528:DC%2BD1cXitlemtrc%3D 18261829
3. SR Bennett FR Carbone F Karamalis, et al. 1998 Help for cytotoxic-T-cell responses is mediated by CD40 signalling Nature 393 478 480 10.1038/30996 1:CAS:528:DyaK1cXjs1Kmtro%3D 9624004 (Pubitemid 28292195)
4. JA Berzofsky 1988 Immunodominance in T lymphocyte recognition Immunol Lett 18 83 92 10.1016/0165-2478(88)90046-6 1:CAS:528:DyaL1cXkvFSktbs%3D 3042616
5. JA Berzofsky KB Cease JL Cornette, et al. 1987 Protein antigenic structures recognized by T cells: potential applications to vaccine design Immunol Rev 98 9 52 10.1111/j.1600-065X.1987.tb00518.x 1:CAS:528: DyaL2sXmtlChurg%3D 2443443
6. MJ Bevan 2004 Helping the CD8(+) T-cell response Nat Rev Immunol 4 595 602 10.1038/nri1413 1:CAS:528:DC%2BD2cXmtFWktro%3D 15286726
7. H Bian J Hammer 2004 Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE Methods 34 468 475 10.1016/j.ymeth.2004.06.002 1:CAS:528:DC%2BD2cXpslCrtbg%3D 15542373 (Pubitemid 39469054)
8. PJ Bjorkman MA Saper B Samraoui, et al. 1987 The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens Nature 329 512 518 10.1038/329512a0 1:CAS:528:DyaL2sXmtlCguro%3D 2443855 (Pubitemid 17131094)
9. UM Braga-Neto ET Marques Jr 2006 From functional genomics to functional immunomics: new challenges, old problems, big rewards PLoS Comput Biol 2 e81 10.1371/journal.pcbi.0020081 16863395 (Pubitemid 44147377)
10. JM Calvo-Calle I Strug MD Nastke, et al. 2007 Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection PLoS Pathog 3 1511 1529 10.1371/journal.ppat.0030144 1:CAS:528:DC%2BD2sXhsVOgu7jF 17937498 (Pubitemid 350085615)
11. RT Carson KM Vignali DL Woodland, et al. 1997 T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage Immunity 7 387 399 10.1016/S1074-7613(00) 80360-X 1:CAS:528:DyaK2sXmsFKjtrY%3D 9324359 (Pubitemid 27446013)
12. WM Cohen S Pouvelle-Moratille XF Wang, et al. 2006 Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule J Immunol 176 5401 5408 1:CAS:528:DC%2BD28XjsFansrw%3D 16622007
13. E Cunha-Neto 1999 MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans Braz J Med Biol Res 32 199 205 10.1590/S0100-879X1999000200008 1:CAS:528:DyaK1MXhslOls7k%3D 10347755
14. Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH (2005) T cell recognition and cytokine profile induced by melanocyte epitopes in HLA-DRB1 0405-positive and negative Vogt-Koyanagi-Harada uveitis patients. Invest Ophthalmol Vis Sci 46:2465-2471
15. MP Davenport AV Hill 1996 Reverse immunogenetics: from HLA-disease associations to vaccine candidates Mol Med Today 2 38 45 10.1016/1357-4310(96) 88757-0 1:CAS:528:DyaK28XhsFSktbg%3D 8796850 (Pubitemid 126408246)
16. AS De Groot BM Jesdale E Szu, et al. 1997 An interactive web site providing major histocompatibility ligand predictions: application to HIV research AIDS Res Hum Retrovir 13 529 531 10.1089/aid.1997.13.529 9135870
17. AS De Groot A Bosma N Chinai, et al. 2001 From genome to vaccine: in silico predictions, ex vivo verification Vaccine 19 4385 4395 10.1016/S0264-410X(01)00145-1 11483263 (Pubitemid 32718661)
18. AS De Groot J McMurry L Moise 2008 Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates Curr Opin Pharmacol 8 620 626 10.1016/j.coph.2008.08.002 18775515
19. C de Lalla T Sturniolo L Abbruzzese, et al. 1999 Cutting edge: identification of novel T cell epitopes in Lol p5a by computational prediction J Immunol 163 1725 1729 10438899
20. S Depil O Moralès FA Castelli, et al. 2007 Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies J Immunother 30 215 226 10.1097/01.cji.0000211338.99137.4f 1:CAS:528:DC%2BD2sXjsVKntLc%3D 17471168 (Pubitemid 46667801)
21. DL Doolan S Southwood R Chesnut, et al. 2000 HLA-DR-promiscuous T cell epitopes from plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles J Immunol 165 1123 1137 1:CAS:528: DC%2BD3cXkvFWitLs%3D 10878392
22. JC Flynn DJ McCormick V Brusic, et al. 2004 Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis Cell Immunol 229 79 85 10.1016/j.cellimm.2004.07.002 1:CAS:528:DC%2BD2cXotlSmtbY%3D 15474522 (Pubitemid 39330215)
23. CT Fonseca E Cunha-Neto AC Goldberg, et al. 2005 Human T cell epitope mapping of the Schistosoma mansoni 14 kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis Microbes Infect 7 204 212 10.1016/j.micinf.2004.10.012 1:CAS:528:DC%2BD2MXisFKjurs%3D 15725385 (Pubitemid 40387424)
24. CT Fonseca E Cunha-Neto AC Goldberg, et al. 2005 Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni infection Clin Exp Immunol 142 539 547 1:CAS:528:DC%2BD2MXhtlWqtrvM 16297167
25. SG Fonseca A Coutinho-Silva LA Fonseca, et al. 2006 Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients AIDS 20 2263 2273 10.1097/01.aids.0000253353.48331.5f 1:CAS:528:DC%2BD28Xht1WqurnM 17117012 (Pubitemid 44789528)
26. A Franco C Ferrari A Sette, et al. 1995 Viral mutations, TCR antagonism and escape from the immune response Curr Opin Immunol 7 524 531 10.1016/0952-7915(95)80098-0 1:CAS:528:DyaK2MXotF2ks7k%3D 7495517
27. TM Fu A Friedman JB Ulmer, et al. 1997 Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization J Virol 71 2715 2721 1:CAS:528:DyaK2sXhvVCqu74%3D 9060624
28. RT Gandhi BD Walker 2002 Immunologic control of HIV-1 Annu Rev Med 53 149 172 10.1146/annurev.med.53.082901.104011 1:CAS:528:DC%2BD38Xitl2mtr4%3D 11818468 (Pubitemid 34177876)
29. TC Garcia CT Fonseca LG Pacifico, et al. 2008 Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice Acta Trop 106 162 167 10.1016/j. actatropica.2008.03.003 1:CAS:528:DC%2BD1cXmt1Ois7Y%3D 18423420
30. U Gowthaman JN Agrewala 2008 In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion J Proteome Res 7 154 163 10.1021/pr070527b 1:CAS:528:DC%2BD2sXhtlCqtLnL 18034454 (Pubitemid 351171127)
31. P Guan IA Doytchinova C Zygouri, et al. 2003 MHCPred: bringing a quantitative dimension to the online prediction of MHC binding Appl Bioinformatics 2 63 66 1:CAS:528:DC%2BD3sXotVOrtb8%3D 15130834
32. Y Guo H Niiya T Azuma, et al. 2005 Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner Blood 106 1415 1418 10.1182/blood-2005-01-0413 1:CAS:528: DC%2BD2MXosVejtLw%3D 15845894 (Pubitemid 41129609)
33. J Hammer E Bono F Gallazzi, et al. 1994 Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning J Exp Med 180 2353 2358 10.1084/jem.180.6.2353 1:CAS:528:DyaK2cXmsFeiur8%3D 7964508 (Pubitemid 24351618)
34. MC Honeyman V Brusic LC Harrison 1997 Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus Ann Med 29 401 404 10.3109/07853899708999369 1:CAS:528: DyaK1cXmtV2lug%3D%3D 9453287
35. JA Hural RS Friedman A McNabb, et al. 2002 Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide based in vitro stimulation J Immunol 169 557 565 1:CAS:528:DC%2BD38XltVKitr8%3D 12077288
36. H Inaba W Martin AS De Groot, et al. 2006 Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease J Clin Endocrinol Metab 91 2286 2294 10.1210/jc.2005-2537 1:CAS:528:DC%2BD28XlvVCgtr0%3D 16595602 (Pubitemid 43855019)
37. LK Iwai M Yoshida J Sidney, et al. 2003 In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals Mol Med 9 209 219 1:CAS:528:DC%2BD2cXmtFyhu7o%3D 15208742
38. LK Iwai M Yoshida A Sadahiro, et al. 2007 T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals Clin Vaccine Immunol 14 474 476 10.1128/CVI.00458-06 1:CAS:528:DC%2BD2sXkvVSkt7s%3D 17329443 (Pubitemid 46732560)
39. AM Khan O Miotto AT Heiny, et al. 2006 A systematic bioinformatics approach for selection of epitope-based vaccine targets Cell Immunol 244 141 147 10.1016/j.cellimm.2007.02.005 1:CAS:528:DC%2BD2sXlsF2mtLc%3D 17434154 (Pubitemid 46733910)
40. A Khanolkar MJ Fuller AJ Zajac 2004 CD4 T cell-dependent CD8 T cell maturation J Immunol 172 2834 2844 1:CAS:528:DC%2BD2cXhsVCrsrg%3D 14978084
41. A Khanolkar VP Badovinac JT Harty 2007 CD8 T cell memory development: CD4 T cell help is appreciated Immunol Res 39 94 104 10.1007/s12026-007-0081-4 1:CAS:528:DC%2BD2sXhtlertbnK 17917058 (Pubitemid 47574900)
42. D Kim T Hoory A Monie, et al. 2008 Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun J Immunol 180 7019 7027 1:CAS:528:DC%2BD1cXltlCrs7o%3D 18453624
43. H Kobayashi Y Song DS Hoon, et al. 2001 Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles Cancer Res 61 4773 4778 1:CAS:528:DC%2BD3MXks1Grtbc%3D 11406551
44. H Kobayashi R Omiya M Ruiz, et al. 2002 Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen Clin Cancer Res 8 3219 3225 1:CAS:528:DC%2BD38XosFKhsbg%3D 12374692
45. E Koren AS De Groot V Jawa, et al. 2007 Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein Clin Immunol 124 26 32 10.1016/j.clim.2007.03.544 1:CAS:528:DC%2BD2sXmvVKquro%3D 17490912 (Pubitemid 46938690)
46. A Lanzavecchia F Sallusto 2001 Antigen decoding by T lymphocytes: from synapses to fate determination Nat Immunol 2 487 492 10.1038/88678 1:CAS:528:DC%2BD3MXkt1yksrs%3D 11376334 (Pubitemid 33705849)
47. NL Letvin JR Mascola Y Sun, et al. 2006 Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys Science 312 1530 1533 10.1126/science.1124226 1:CAS:528:DC%2BD28XltlGltrc%3D 16763152 (Pubitemid 43865893)
48. H Li CF Xu S Blais, et al. 2009 Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes J Immunol 182 6369 6378 10.4049/jimmunol.0804287 1:CAS:528:DC%2BD1MXltlymsrk%3D 19414790
49. HH Lin GL Zhang S Tongchusak, et al. 2008 Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research BMC Bioinformatics 9 suppl 12 S22 10.1186/1471-2105-9-S12-S22 19091022
50. Livingstone AM, Wilson EB, Ontiveros F, Wang JC (2009) Unravelling the mechanisms of help for CD8+ T cell responses. Immunol Res 45(2-3):209-217
51. R Mallone GT Nepom 2004 MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete Clin Immunol 110 232 242 10.1016/j.clim.2003.11.004 1:CAS:528:DC%2BD2cXis1WhtL8%3D 15047201 (Pubitemid 38402003)
52. DG McNeel LD Nguyen ML Disis 2001 Identification of T helper epitopes from prostatic acid phosphatase Cancer Res 61 5161 5167 1:CAS:528: DC%2BD3MXltVCjsrw%3D 11431355
53. S Mitra-Kaushik J Cruz LJ Stern, et al. 2007 Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses J Immunol 179 1303 1312 1:CAS:528: DC%2BD2sXnt1Wntb0%3D 17617623
54. L Moise AS De Groot 2006 Putting immunoinformatics to the test Nat Biotechnol 24 791 792 10.1038/nbt0706-791 1:CAS:528:DC%2BD28XmvFagu7o%3D 16841062 (Pubitemid 44086616)
55. KD Moudgil H Deng NK Nanda, et al. 1996 Antigen processing and T cell repertoires as crucial aleatory features in induction of autoimmunity J Autoimmun 9 223 227 10.1006/jaut.1996.0028 (Pubitemid 26163867)
56. AS Mustafa 2009 Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis Scand J Immunol 69 213 222 10.1111/j.1365-3083.2008. 02221.x 1:CAS:528:DC%2BD1MXjvFOrtLk%3D 19281533
57. M Nielsen C Lundegaard T Blicher, et al. 2008 Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan PLoS Comput Biol 4 e1000107 10.1371/journal.pcbi.1000107 18604266
58. P Novy M Quigley X Huang, et al. 2007 CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses J Immunol 179 8243 8251 1:CAS:528:DC%2BD2sXhtlyitrfE 18056368
59. T Ohkuri D Wakita K Chamoto, et al. 2009 Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells Br J Cancer 100 1135 1143 10.1038/sj.bjc.6604966 1:CAS:528:DC%2BD1MXktVGktrs%3D 19277034
60. M Panigada T Sturniolo G Besozzi, et al. 2002 Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins Infect Immun 70 79 85 10.1128/IAI.70.1.79-85.2002 1:CAS:528:DC%2BD3MXptlKhsbw%3D 11748166 (Pubitemid 34028601)
61. M Pizza V Scarlato V Masignani, et al. 2000 Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 1816 1820 10.1126/science.287.5459.1816 1:CAS:528:DC%2BD3cXhvVWksbk%3D 10710308 (Pubitemid 30143965)
62. M Rajapakse B Schmidt L Feng, et al. 2007 Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms BMC Bioinformatics 8 459 10.1186/1471-2105-8-459 18031584 (Pubitemid 351150055)
63. NK Rajasagi SH Kassim CM Kollias, et al. 2009 CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1 J Virol 83 5256 5268 10.1128/JVI.01997-08 1:CAS:528:DC%2BD1MXlvVGhtbg%3D 19279095
64. H Rammensee J Bachmann NP Emmerich, et al. 1999 SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50 213 219 10.1007/s002510050595 1:CAS:528:DyaK1MXntlalsbs%3D 10602881
65. R Rappuoli 2000 Reverse vaccinology Curr Opin Microbiol 3 445 450 10.1016/S1369-5274(00)00119-3 1:CAS:528:DC%2BD3cXotVOit70%3D 11050440
66. PA Reche JP Glutting EL Reinherz 2002 Prediction of MHC class I binding peptides using profile motifs Hum Immunol 63 701 709 10.1016/S0198-8859(02) 00432-9 1:CAS:528:DC%2BD38XmtVWnsLs%3D 12175724 (Pubitemid 34983301)
67. JP Ridge F Di Rosa P Matzinger 1998 A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell Nature 393 474 478 10.1038/30989 1:CAS:528:DyaK1cXjs1Kms7s%3D 9624003 (Pubitemid 28292194)
68. J Robinson MJ Waller SC Fail, et al. 2009 The IMGT/HLA database Nucleic Acids Res 37 Database issue D1013 D1017 10.1093/nar/gkn662 1:CAS:528: DC%2BD1cXhsFejt7nN 18838392
69. DS Rosa F Tzelepis MG Cunha, et al. 2004 The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate Immunol Lett 92 259 268 10.1016/j.imlet.2004.01.006 1:CAS:528:DC%2BD2cXjtV2gtLk%3D 15081621 (Pubitemid 38476986)
70. DS Rosa LK Iwai F Tzelepis, et al. 2006 Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus) Microbes Infect 8 2130 2137 10.1016/j.micinf.2006.03.012 1:CAS:528:DC%2BD28XpsVOlsLY%3D 16797207 (Pubitemid 44335876)
71. AJ Sant FA Chaves SA Jenks, et al. 2005 The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes Immunol Rev 207 261 278 10.1111/j.0105-2896.2005.00307.x 1:CAS:528:DC%2BD2MXhtFOqtL%2FL 16181342 (Pubitemid 41415023)
72. C Saravia P Martinez DS Granados, et al. 2008 Identification and evaluation of universal epitopes in Plasmodium vivax duffy binding protein Biochem Biophys Res Commun 377 1279 1283 10.1016/j.bbrc.2008.10.153 1:CAS:528:DC%2BD1cXhsVGhu7jP 19000655
73. SP Schoenberger RE Toes EI van der Voort, et al. 1998 T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 393 480 483 10.1038/31002 1:CAS:528:DyaK1cXjs1Kmtbw%3D 9624005 (Pubitemid 28292196)
74. D Serruto R Rappuoli 2006 Post-genomic vaccine development FEBS Lett 580 2985 2992 10.1016/j.febslet.2006.04.084 1:CAS:528:DC%2BD28XltVKntb8%3D 16716781 (Pubitemid 43729171)
75. A Sette J Fikes 2003 Epitope-based vaccines: an update on epitope identification, vaccine design and delivery Curr Opin Immunol 15 461 470 10.1016/S0952-7915(03)00083-9 1:CAS:528:DC%2BD3sXlvFymurY%3D 12900280 (Pubitemid 36934509)
76. H Singh GP Raghava 2003 ProPred1: prediction of promiscuous MHC Class-I binding sites Bioinformatics 19 1009 1014 10.1093/bioinformatics/btg108 1:CAS:528:DC%2BD3sXktVCgsrY%3D 12761064 (Pubitemid 36675822)
77. CM Smith NS Wilson J Waithman, et al. 2004 Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity Nat Immunol 5 1143 1148 10.1038/ni1129 1:CAS:528:DC%2BD2cXoslSktr0%3D 15475958 (Pubitemid 39549628)
78. LJ Stern JH Brown TS Jardetzky, et al. 1994 Crystal structure of the human class II MHC protein MHC-DR1 complexed with an influenza virus peptide Nature 368 215 221 10.1038/368215a0 1:CAS:528:DyaK2cXktlaltLs%3D 8145819 (Pubitemid 24108837)
79. T Sturniolo E Bono J Ding, et al. 1999 Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices Nat Biotechnol 17 555 561 10.1038/9858 1:CAS:528:DyaK1MXjs1Kgu7k%3D 10385319 (Pubitemid 29262918)
80. T Tatsumi LS Kierstead E Ranieri, et al. 2003 MAGE-6 encodes HLA-DRbeta1 0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma Clin Cancer Res 9 947 954 1:CAS:528:DC%2BD3sXhvFKiurg%3D 12631591
81. Valentino M, Frelinger J (2009) An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis. Immunol Res 45(2-3):218-228
82. XF Wan G Chen F Luo, et al. 2007 A quantitative genotype algorithm reflecting H5N1 Avian influenza niches Bioinformatics 23 2368 2375 10.1093/bioinformatics/btm354 1:CAS:528:DC%2BD2sXhtVOku7%2FK 17623701 (Pubitemid 47423833)
83. P Wang J Sidney C Dow, et al. 2008 A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach PLoS Comput Biol 4 e1000048 10.1371/journal.pcbi.1000048 18389056 (Pubitemid 351656722)
84. DI Watkins DR Burton EG Kallas, et al. 2008 Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans Nat Med 14 617 621 10.1038/nm.f.1759 1:CAS:528:DC%2BD1cXmvVCnsbg%3D 18535579 (Pubitemid 351809543)
85. CC Wilson B Palmer S Southwood, et al. 2001 Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes J Virol 75 4195 4207 10.1128/JVI.75.9.4195-4207.2001 1:CAS:528:DC%2BD3MXivFOkt7s%3D 11287569 (Pubitemid 32410132)
86. D Wodarz VA Jansen 2001 The role of T cell help for anti-viral CTL responses J Theor Biol 211 419 432 10.1006/jtbi.2001.2358 1:CAS:528: DC%2BD3MXlsVWgur4%3D 11476625 (Pubitemid 32730529)
87. H Xu J Wipasa H Yan, et al. 2002 The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection J Exp Med 195 881 892 10.1084/jem.20011174 1:CAS:528:DC%2BD38Xis1Oltbg%3D 11927632 (Pubitemid 34286759)
88. X Yang X Yu 2009 An introduction to epitope prediction methods and software Rev Med Virol 19 77 96 10.1002/rmv.602 1:CAS:528:DC%2BD1MXkt1eltr8%3D 19101924
89. GL Zhang KN Srinivasan A Veeramani, et al. 2005 PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse Nucleic Acids Res 33 Web Server issue W180 W183 10.1093/nar/gki479 1:CAS:528:DC%2BD2MXlslyqtbw%3D 15980450 (Pubitemid 44529904)
90. GL Zhang AM Khan KN Srinivasan, et al. 2007 Neural models for predicting viral vaccine targets J Bioinform Comput Biol 3 1207 1225 10.1142/ S0219720005001466
91. S Zhang H Zhang J Zhao 2009 The role of CD4 T cell help for CD8 CTL activation Biochem Biophys Res Commun 384 405 408 10.1016/j.bbrc.2009.04.134 1:CAS:528:DC%2BD1MXmsVCgsLc%3D 19410556